Master the Skills Needed to Overcome the Challenges of Modern Paragraph IV Litigation

As the industry prepares to address the fallout of global pharmaceutical patent losses of billions of dollars and the impact of evolving law, regulation and policy impacting the Hatch-Waxman landscape, the time for this conference has never been more relevant.

Learn from preeminent patent litigators representing brand name and generic drug makers as they provide key insights on:

  • Pending Hatch-Waxman reform measures which may impact your practice and change the balance of power between brand names and generics
  • The impact of new Section 101 and 112 challenges on ANDA litigation
  • Evolving Doctrine of Equivalents jurisprudence and how it is affecting Hatch-Waxman cases
  • Novel and strategic use of 12(b) and 12 (c) motions
  • The application of blocking patents post-Acorda
  • New developments impacting parallel proceedings
  • The economic impact of recent FDA activity affecting market access and exclusivities

Download The Complete Agenda and Faculty List Now!

Sign up and stay tuned for more exciting announcement about Paragraph IV Disputes Symposium and our incredible speaker line-up!

Get judicial insights on the complex challenges facing both brand name and generic drug manufacturers:

United States District Court

Honorable Rebecca R. Pallmeyer

Honorable Rebecca R. Pallmeyer

Chief Judge
Northern District of Illinois

Honorable Tonianne Bongiovanni

Honorable Tonianne Bongiovanni

Magistrate Judge
District of New Jersey

Honorable Roy Payne

Honorable Roy Payne

Magistrate Judge
Eastern District of Texas

Honorable Sidney I. Schenkier

Honorable Sidney I. Schenkier

Magistrate Judge
Northern District of Illinois

United States Patent and Trademark Office, Patent Trial and Appeal Board

Ryan M. Daniel

Honorable Jacqueline Wright Bonilla

Vice Chief Administrative Patent Judge

Andrea Hutchison

Honorable Michelle N. Ankenbrand

Lead Administrative Patent Judge

Andrea Hutchison

Honorable Rama G. Elluru

Administrative Patent Judge



Ryan M. Daniel

James Weingarten

Federal Trade Commission (Washington, DC)

A few words from our Co-Chairs:

Ryan M. Daniel

Ryan M. Daniel

Acting Chief Patent Counsel
Fresenius Kabi USA, LLC

“I’m excited to participate in ACI’s 2019 Paragraph IV Conference here in Chicago. It’s a welcome opportunity to engage with colleagues regarding the evolving landscape of Hatch-Waxman law and the pharmaceutical industry.”

Andrea Hutchison

Andrea Hutchison

Associate General Counsel, IP Litigation
Gilead Sciences

“ACI’s Paragraph IV Conference series offers a great opportunity to convene and exchange ideas with subject matter experts from all over the country. I am delighted to return to Chicago and to meet with our many talented Hatch-Waxman litigators and colleagues in the industry.”

Who you will meet:

Patent attorneys and litigators (in-house & law firms) who represent:

  • Brand name pharmaceutical companies
  • Generic pharmaceutical companies
  • Biopharmaceutical companies

Best rates expire soon

Reserve your seat today by calling 888-224-2480 or register online.

Event Contacts

Sponsorship Opportunities:

American Conference Institute
[email protected]

Media Partnership Opportunities:

Linda Lam
[email protected]

Programme Information and Speaking:

Joseph Gallagher
[email protected]

Connect With Us



Save On Your Stay

 W Chicago – City Center

172 West Adams Street, Chicago, IL 60603


The American Conference Institute is pleased to offer our delegates a negotiated rate for hotel rooms at the W Chicago – City Center. To take advantage of these rates, please contact the hotel directly on or before Saturday, August 31, 2019 and quote "ACI's Paragraph IV Conference".

Please note that guestroom rate is subject to availability.